Eco R1 Capital, LLC Innate Pharma Sa Transaction History

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$5.36 - $8.2 $23.9 Million - $36.6 Million
-4,465,668 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$3.8 - $7.95 $303,186 - $634,298
-79,786 Reduced 1.76%
4,465,668 $29.8 Million
Q4 2019

Feb 14, 2020
BUY
$5.66 - $6.55 $25.7 Million - $29.8 Million
4,545,454 New
4,545,454 $29.3 Million

Others Institutions Holding IPHA

# of Institutions
9
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Innate Pharma SA

IPHA Quotes by TradingView
  • Ticker IPHA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,893,000
  • Market Cap $141M
  • Description
  • Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...
More about IPHA
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email